Cargando…
Immunomodulatory asthma therapy in the equine animal model: A dose‐response study and evaluation of a long‐term effect
INTRODUCTION: Equine asthma represents a naturally occurring animal model for human allergic neutrophilic asthma. Inhalative nanoparticle‐bound cytosine‐phosphate‐guanosine (CpG‐GNP) immunotherapy, independent of specific allergens, has already shown promising clinical and immunological results in p...
Autores principales: | Klier, John, Bartl, Carolin, Geuder, Sabine, Geh, Katharina J., Reese, Sven, Goehring, Lutz S., Winter, Gerhard, Gehlen, Heidrun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688086/ https://www.ncbi.nlm.nih.gov/pubmed/31141308 http://dx.doi.org/10.1002/iid3.252 |
Ejemplares similares
-
A comparison of nanoparticullate CpG immunotherapy with and without allergens in spontaneously equine asthma‐affected horses, an animal model
por: Klier, John, et al.
Publicado: (2017) -
Inhalative Nanoparticulate CpG Immunotherapy in Severe Equine Asthma: An Innovative Therapeutic Concept and Potential Animal Model for Human Asthma Treatment
por: Klier, John, et al.
Publicado: (2022) -
Metalloproteinases and their Inhibitors under the Course of Immunostimulation by CPG-ODN and Specific Antigen Inhalation in Equine Asthma
por: Barton, Ann Kristin, et al.
Publicado: (2019) -
Pulmonary Remodeling in Equine Asthma: What Do We Know about Mediators of Inflammation in the Horse?
por: Barton, Ann Kristin, et al.
Publicado: (2016) -
A Systematic Approach to Dissection of the Equine Brain–Evaluation of a Species-Adapted Protocol for Beginners and Experts
por: Bitschi, Maya-Lena, et al.
Publicado: (2020)